Funding for this research was provided by:
National Natural Science Foundation of China (81571273, 81571274, 81501125)
Omics-based precision medicine of epilepsy being entrusted by Key Research Project of the Ministry of Science and Technology of China (2016YFC0904400)
Natural Science Foundation of Guangdong Province (2014A030313489)
Medical Scientific Research Foundation of Guangdong Province (A2013268)
Received: 29 August 2017
Accepted: 8 March 2018
First Online: 20 March 2018
Ethics approval and consent to participate
: The study protocol was approved by the ethics committee of the Second Affiliated Hospital of Guangzhou Medical University, and written informed consent was obtained from all patients or their parents.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.